Trial Profile
A Randomised, Cross-over Phase II Study to Investigate the Efficacy and Safety of Glucarpidase for Routine Use After High Dose Methotrexate in Patients With Bone Sarcoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Glucarpidase (Primary) ; Folinic acid; Methotrexate
- Indications Osteosarcoma
- Focus Therapeutic Use
- Acronyms GLU-1
- 03 Jun 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
- 01 Jul 2014 New source identified and integrated (European Clinical Trials Database: EudraCT2006-003203-40)
- 10 Jan 2014 New trial record